Cohort profile: Epigenetics in Pregnancy (EPIPREG) - population-based sample of European and South Asian pregnant women with epigenome-wide DNA methylation (850k) in peripheral blood leukocytes.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 18 03 2021
accepted: 01 08 2021
entrez: 13 8 2021
pubmed: 14 8 2021
medline: 29 12 2021
Statut: epublish

Résumé

Pregnancy is a valuable model to study the association between DNA methylation and several cardiometabolic traits, due to its direct potential to influence mother's and child's health. Epigenetics in Pregnancy (EPIPREG) is a population-based sample with the aim to study associations between DNA-methylation in pregnancy and cardiometabolic traits in South Asian and European pregnant women and their offspring. This cohort profile paper aims to present our sample with genetic and epigenetic data and invite researchers with similar cohorts to collaborative projects, such as replication of ours or their results and meta-analysis. In EPIPREG we have quantified epigenome-wide DNA methylation in maternal peripheral blood leukocytes in gestational week 28±1 in Europeans (n = 312) and South Asians (n = 168) that participated in the population-based cohort STORK Groruddalen, in Norway. DNA methylation was measured with Infinium MethylationEPIC BeadChip (850k sites), with technical validation of four CpG sites using bisulphite pyrosequencing in a subset (n = 30). The sample is well characterized with few missing data on e.g. genotype, universal screening for gestational diabetes, objectively measured physical activity, bioelectrical impedance, anthropometrics, biochemical measurements, and a biobank with maternal serum and plasma, urine, placenta tissue. In the offspring, we have repeated ultrasounds during pregnancy, cord blood, and anthropometrics up to 4 years of age. We have quantified DNA methylation in peripheral blood leukocytes in nearly all eligible women from the STORK Groruddalen study, to minimize the risk of selection bias. Genetic principal components distinctly separated Europeans and South Asian women, which fully corresponded with the self-reported ethnicity. Technical validation of 4 CpG sites from the methylation bead chip showed good agreement with bisulfite pyrosequencing. We plan to study associations between DNA methylation and cardiometabolic traits and outcomes.

Identifiants

pubmed: 34388220
doi: 10.1371/journal.pone.0256158
pii: PONE-D-21-08932
pmc: PMC8362992
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0256158

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Br J Nutr. 2017 Apr;117(7):985-993
pubmed: 28468694
Scand J Med Sci Sports. 2014 Oct;24(5):e389-97
pubmed: 24894027
Nephron Clin Pract. 2012;120(3):c162-7
pubmed: 22722148
Epigenetics. 2020 Apr;15(4):358-368
pubmed: 31552803
Diabetes. 2019 Dec;68(12):2315-2326
pubmed: 31506343
Clin Epigenetics. 2016 Jan 20;8:6
pubmed: 26798409
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Dis Model Mech. 2010 May-Jun;3(5-6):290-7
pubmed: 20427558
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Food Nutr Res. 2013 Jul 08;57:
pubmed: 23843779
Eur J Endocrinol. 2012 Oct;167(4):579-88
pubmed: 22889687
Diabetologia. 2016 Jan;59(1):130-138
pubmed: 26433941
Am J Hum Genet. 2017 Dec 7;101(6):888-902
pubmed: 29198723
Eur J Endocrinol. 2018 Dec 1;179(6):363-372
pubmed: 30324795
BMC Pregnancy Childbirth. 2015 Apr 03;15:84
pubmed: 25879215
Eur J Endocrinol. 2015 Jun;172(6):649-56
pubmed: 25740849
Environ Health Perspect. 2012 Oct;120(10):1425-31
pubmed: 22851337
Clin Epigenetics. 2016 Jan 28;8:13
pubmed: 26823690
PLoS One. 2020 Jan 30;15(1):e0227728
pubmed: 31999706
Hum Mol Genet. 2015 Aug 1;24(15):4464-79
pubmed: 25935004
Diabetes Res Clin Pract. 2014 Mar;103(3):341-63
pubmed: 24847517
Clin Epigenetics. 2019 Jul 1;11(1):97
pubmed: 31262328
J Hypertens. 2016 Jun;34(6):1151-9
pubmed: 27088633
Kidney Int. 2008 Nov;74(9):1116-20
pubmed: 18596728
Circ Cardiovasc Genet. 2016 Oct;9(5):436-447
pubmed: 27651444
Nucleic Acids Res. 1988 Feb 11;16(3):1215
pubmed: 3344216
J Clin Invest. 2005 Mar;115(3):485-91
pubmed: 15765129
Scand J Med Sci Sports. 2014 Jun;24(3):594-601
pubmed: 23278771
Addict Biol. 2021 Jan;26(1):e12855
pubmed: 31789449
Med Sci Sports Exerc. 2011 Jul;43(7):1334-59
pubmed: 21694556
Epigenomics. 2016 May;8(5):599-618
pubmed: 26864933
PLoS Genet. 2010 Jul 29;6(7):e1001043
pubmed: 20686660
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Am J Obstet Gynecol. 1991 Dec;165(6 Pt 1):1667-72
pubmed: 1750458
Nature. 2017 Jan 5;541(7635):81-86
pubmed: 28002404
BMC Res Notes. 2012 Apr 30;5:210
pubmed: 22546179
J Dev Orig Health Dis. 2021 Jun;12(3):373-383
pubmed: 32873364
Neuropsychopharmacology. 2013 Jan;38(1):23-38
pubmed: 22781841
Int J Mol Sci. 2019 Feb 26;20(5):
pubmed: 30813608
Curr Opin Obstet Gynecol. 2003 Dec;15(6):465-71
pubmed: 14624211
Bioinformatics. 2018 Dec 1;34(23):3983-3989
pubmed: 29931280
Clin Epigenetics. 2017 Feb 7;9:15
pubmed: 28194238
Early Hum Dev. 2015 Sep;91(9):547-54
pubmed: 26197025
Epigenetics Chromatin. 2016 Jun 29;9:26
pubmed: 27358654
Eur J Endocrinol. 2012 Feb;166(2):317-24
pubmed: 22108914
Clin Epigenetics. 2021 Feb 23;13(1):40
pubmed: 33622391
Sci Rep. 2017 Jul 26;7(1):6605
pubmed: 28747766
Lancet Diabetes Endocrinol. 2015 Jul;3(7):526-534
pubmed: 26095709
Int J Obes (Lond). 2014 Jan;38(1):76-81
pubmed: 24051503
J Womens Health (Larchmt). 2011 May;20(5):695-701
pubmed: 21453034
PLoS Genet. 2013 Jun;9(6):e1003572
pubmed: 23825961
Circ Res. 2019 Oct 11;125(9):824-833
pubmed: 31510868
Scand J Public Health. 2010 Nov;38(5 Suppl):60-70
pubmed: 21062840
Diabetes Care. 2021 Sep;44(9):1992-1999
pubmed: 34116986
PLoS One. 2013 Aug 29;8(8):e73058
pubmed: 24009731

Auteurs

Nicolas Fragoso-Bargas (N)

Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Julia O Opsahl (JO)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Nadezhda Kiryushchenko (N)

Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Department of Bioscience, University of Oslo, Oslo, Norway.

Yvonne Böttcher (Y)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway.
Helmholtz-Institute for Metabolic, Adiposity and Vascular Research, Leipzig, Germany.

Sindre Lee-Ødegård (S)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Elisabeth Qvigstad (E)

Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Kåre Rønn Richardsen (KR)

Faculty of Health Sciences, Department of Physiotherapy, Oslo Metropolitan University, Oslo, Norway.

Christin W Waage (CW)

Faculty of Health Sciences, Department of Physiotherapy, Oslo Metropolitan University, Oslo, Norway.
Department of General Practice, General Practice Research Unit (AFE), Institute of Health and Society, University of Oslo, Oslo, Norway.

Line Sletner (L)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Pediatric and Adolescents Medicine, Akershus University Hospital, Lørenskog, Norway.

Anne Karen Jenum (AK)

Department of General Practice, General Practice Research Unit (AFE), Institute of Health and Society, University of Oslo, Oslo, Norway.

Rashmi B Prasad (RB)

Lund University Diabetes Centre, Malmö, Sweden.

Leif C Groop (LC)

Lund University Diabetes Centre, Malmö, Sweden.

Gunn-Helen Moen (GH)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, Australia.
Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Population Health Science, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Kåre I Birkeland (KI)

Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Christine Sommer (C)

Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH